Gentofte Hospital

• Tor Biering-Sørensen

  Lead investigator

Sources: openalex.org

• NCT03778554

  Collaborator, Phase 4, Active, not recruiting, 2,760 people, Dec 19, 2018

• Novo Nordisk Foundation

  Skolarstipendier, The Use of 3D Echocardiography in Early Cardiovascular Risk Stratification of Chronic Kidney Disease Patients, nnf-grant-42a20bae3d67e72b, DKK 150K, 2020, Jan 1, 2020

Sources: openalex.org

• Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower-risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo-controlled trial

  Oct 1, 2026

• Thymic Involution and Function in People With HIV and General Population Controls: A Cross-Sectional Analysis From Two Danish Cohort Studies

  Oct 1, 2026

• Prevalence of sarcopenia in older patients with colorectal cancer prior to chemotherapy

  Sep 24, 2026

• Epitope placement tunes CSF tau biomarkers: Comparison of P-tau217 and BD-tau designs

  Sep 22, 2026

• Muscle fibre denervation in ageing

  Jul 15, 2026

• LEAP2 Reduces Ad Libitum Food Intake and Attenuates Postprandial Glucose Excursions in Men With Obesity

  Jun 1, 2026

• Hepcidin in hospitalized older medical patients: associations with inflammation, anemia, frailty, comorbidity, and renal function

  May 19, 2026

• Genomic analyses implicate hormonal and metabolic dysregulation in polycystic ovary syndrome

  Apr 23, 2026

• Lifestyle characteristics and plasma biomarkers for risk of MASLD differ by sex in the general population

  Mar 16, 2026

• Changes in ultraviolet a radiation-induced thymidine dimers and erythema after oral nicotinamide or polypodium leucotomos extract in healthy volunteers: a randomized intraindividual trial

  Mar 16, 2026

• The Effect of Empagliflozin on Left Ventricular Mass and Volumes in Older Adult Individuals With Overweight and High Risk of Heart Failure: The Empire Prevent Cardiac Trial

  Mar 12, 2026

• Empagliflozin and functional aerobic capacity in individuals with increased risk of heart failure: The Empire Prevent Cardiac trial

  Mar 7, 2026

• Occupation-centred intervention for age-related dysphagia: A proof-of-concept study

  Jan 28, 2026

• Geriatric prehabilitation prior to surgery for kidney tumors: Study protocol for Pre-KiT - A randomized controlled trial

  Jan 26, 2026

• Effects of Atrial Fibrillation Screening According to Echocardiographic Measures of Cardiac Structure and Function: A Post Hoc Analysis of the LOOP Randomized Clinical Trial

  Dec 30, 2025

• Dizziness and impaired postural balance in older patients receiving chemotherapy treatment: A systematic review and meta-analysis

  Dec 5, 2025

• GDF-15 plasma levels are elevated in mobility-limited older adults with frailty and sarcopenia-results from the BIOFRAIL study

  Nov 25, 2025

• Intra- and Inter-Rater Reproducibility of Measures of Physical Performance in Patients with COPD

  Sep 24, 2025

• Frailty is associated with a history of falls among mobility-limited older adults-cross-sectional multivariate analysis from the BIOFRAIL study

  May 27, 2025

• The effectiveness of exercise-based interventions on muscle mass, muscle strength, functional performance, aerobic capacity, and health-related quality of life in adults with malignant lymphoma undergoing chemotherapy: a systematic review of randomized controlled trials

  Jan 28, 2025

Sources: openalex.org, api.crossref.org

• Hormone may predict blood sugar response in schizophrenia

  Schizophrenia bulletin open, Oct 28, 2026

• Early Initiation of SGLT2 inhibitor and Mortality in Heart Failure With Reduced Ejection Fraction: A Target Trial Emulation Study

  European heart journal. Cardiovascular pharmacotherapy, Oct 27, 2026

• GLP-1 drugs linked to lower stroke risk in atrial fibrillation

  ESC Congress 2026 abstract, Oct 26, 2026

• Empagliflozin reduces a blood marker of tissue scarring

  ESC Congress 2026 abstract, Oct 26, 2026

• Elevated remnant cholesterol explains a substantial part of excess cardiovascular risk in the metabolic syndrome

  ESC Congress 2026 abstract, Oct 26, 2026

• Early magnesium changes may contribute to SGLT2 inhibitor–induced left ventricular mass regression in CKD

  ESC Congress 2026 abstract, Oct 26, 2026

• Diastolic dysfunction and structural response to SGLT2 inhibition in chronic kidney disease: the DECODE-CKD trial

  ESC Congress 2026 abstract, Oct 26, 2026

• Dyskalemia, cardiac structure and function, and risk of adverse cardiovascular events in patients with chronic kidney disease

  ESC Congress 2026 abstract, Oct 26, 2026

• Blood particle linked to highest artery disease risk at 70–100

  ESC Congress 2026 abstract, Oct 26, 2026

• Type 2 diabetes linked to higher early dementia risk

  ESC Congress 2026 abstract, Oct 26, 2026

• The role of 3D body scan derived anthropometric measurements in predicting subclinical atherosclerosis in the REACT cohort

  ESC Congress 2026 abstract, Oct 26, 2026

• Cumulative smoking exposure and prevalence of silent atherosclerosis in the REACT study

  ESC Congress 2026 abstract, Oct 26, 2026

• Improving LDL-C goal attainment: real-world outcomes and the impact of guideline optimization

  ESC Congress 2026 abstract, Oct 26, 2026

• Impact of atherogenic lipoproteins and inflammatory markers on silent atherosclerosis

  ESC Congress 2026 abstract, Oct 26, 2026

• Performance of SCORE2 to identify silent atherosclerosis in adults aged 60–70 years: a sub-analysis from the REACT study

  ESC Congress 2026 abstract, Oct 26, 2026

• Low education status is associated with greater extent of silent atherosclerosis: preliminary data from the REACT study

  ESC Congress 2026 abstract, Oct 26, 2026

• Effects of colchicine on cardiac structure and function in patients with hypertension: a prespecified secondary analysis of the COlchicine HypERtENsion Trial (COHERENT)

  ESC Congress 2026 abstract, Oct 26, 2026

• Social disadvantages link to more deaths after valve replacement

  ESC Congress 2026 abstract, Oct 26, 2026

• Home care linked to deaths after first catheter-placed aortic valve

  ESC Congress 2026 abstract, Oct 26, 2026

• Heart attacks are linked to a higher early risk of dementia

  ESC Congress 2026 abstract, Oct 26, 2026